Your browser doesn't support javascript.
[Structural characteristics and catalytic cycle of dihydroorotate dehydrogenase-a review].
Ren, Xiaoli; Luo, Fen; Li, Xixi; Yi, Sha; Yang, Bing; Jiang, Zhiyong.
  • Ren X; Food and Drug Teaching and Research Department, School of Environment and Quality Testing, Chongqing Chemical Industry Vocational College, Chongqing 401228, China.
  • Luo F; Research Institute of Surgery and Daping Hospital, Third Military Medical University, Chongqing 400042, China.
  • Li X; Food and Drug Teaching and Research Department, School of Environment and Quality Testing, Chongqing Chemical Industry Vocational College, Chongqing 401228, China.
  • Yi S; Food and Drug Teaching and Research Department, School of Environment and Quality Testing, Chongqing Chemical Industry Vocational College, Chongqing 401228, China.
  • Yang B; Food and Drug Teaching and Research Department, School of Environment and Quality Testing, Chongqing Chemical Industry Vocational College, Chongqing 401228, China.
  • Jiang Z; Food and Drug Teaching and Research Department, School of Environment and Quality Testing, Chongqing Chemical Industry Vocational College, Chongqing 401228, China.
Sheng Wu Gong Cheng Xue Bao ; 36(12): 2732-2740, 2020 Dec 25.
Article in Chinese | MEDLINE | ID: covidwho-1005126
ABSTRACT
Dihydroorotate dehydrogenase is a flavin-dependent mitochondrial enzyme to catalyze the fourth step of the de novo synthesis of pyrimidine and to oxidize dihydroorotate to orotate. By selectively inhibiting dihydroorotate dehydrogenase, thereby inhibiting pyrimidine synthesis, the enzyme has been developed for the treatment of cancer, autoimmune diseases, bacterial or viral infections, parasitic diseases and so on. The development of inhibitory drugs requires a detailed understanding of the structural characteristics and catalytic cycle mechanism of dihydroorotate dehydrogenase. Therefore, this paper reviews these two aspects, and indicates perspectives of these inhibitors in clinical application.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Oxidoreductases Acting on CH-CH Group Donors Type of study: Prognostic study Language: Chinese Journal: Sheng Wu Gong Cheng Xue Bao Journal subject: Biotechnology Year: 2020 Document Type: Article Affiliation country: J.cjb.200166

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Oxidoreductases Acting on CH-CH Group Donors Type of study: Prognostic study Language: Chinese Journal: Sheng Wu Gong Cheng Xue Bao Journal subject: Biotechnology Year: 2020 Document Type: Article Affiliation country: J.cjb.200166